Abdelrahman Hafez
Abdelrahman Hafez has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Dina M Abdelaziz
Department of Radiotherapy, National Cancer Institute, Cairo, Egypt
2 shared publicationsDina M. Abdel-Aziz
1 shared publicationDina M. Abdelaziz
Baheya Ctr Early Detect & Treatment Breast Canc, Dept Radiotherapy, Giza, Egypt
1 shared publication- Dina M. Abdelaziz
Radiotherapy Department, Baheya Hospital, Giza, Egypt
1 shared publication Heba M. Fahmy
Cairo Univ, Fac Sci, Dept Biophys, Cairo 12613, Egypt
1 shared publication- Islam Tarek Mahmoud Mustafa
Department of Radiation Oncology, Warith International Cancer Institute (WICI)/Al-Thaqalayne Cancer Hospital, Basra, Iraq
1 shared publication
Latest Publications
- Open Access
- 4 June 2026
- Published by Elsevier in Journal of Radiation Research and Applied Sciences
- Vol. 19 (2)
Feasibility of high-energy flattening filter-free beams in stereotactic radiotherapy of centrally located non-small cell lung cancer
- 4 June 2026
- Published by Elsevier in Journal of Radiation Research and Applied Sciences
- Vol. 19 (2)
Open AccessFeasibility of high-energy flattening filter-free beams in stereotactic radiotherapy of centrally located non-small cell lung cancer
- 8 February 2024
- Published by Elsevier in Medical Dosimetry
- Vol. 49 (3) , 232-238
Efficacy of flattening filter-free beams with the acuros XB algorithm in thoracic spine stereotactic body radiation therapy
- 8 February 2024
- Published by Elsevier in Medical Dosimetry
- Vol. 49 (3) , 232-238
Efficacy of flattening filter-free beams with the acuros XB algorithm in thoracic spine stereotactic body radiation therapy
- 30 June 2021
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 7 (4) , 045026
Quantifying inter- and intra-fraction variations of breast cancer radiotherapy with skin dose measurements
Aim . The aim of the current study was to compare between the deep inspiration breath-hold (DIBH) technique and free-breathing (FB) method in the treatment delivery uncertainty of breast cancer radiotherapy using skin dose measurements. Methods . In a prospective manner, eighty patients were randomly selected for skin dose measurements, and they were assigned to two groups. DIBH (40 patients) and FB (40 patients). The systematic inter-fraction dose variation was quantified using the mean percentage error (MPE) between the average measured total dose per session in three consecutive sessions and the corresponding calculated point dose from the treatment planning system. The random inter-fraction dose variation was quantified using the standard deviation (SD) of the dose delivered by the medial or lateral tangential fields, or the total session dose in the three sessions (SD MT , SD LT , or SD total , respectively). While the random intra-fraction dose variation was quantified using the SD of the dose difference between the medial and lateral tangential fields in three consecutive sessions (SD MT-LT ). Results . There was no statistically significant difference in MPE between the DIBH and FB groups (p = 0.583). Moreover, the mean SD total and SD MT of the DIBH group were significantly lower than that of the FB group (2.75 ± 2.33 cGy versus 4.45 cGy ± 4.33, p = 0.048) and (1.94 ± 1.63 cGy versus 3.76 ± 3.42 cGy, p = 0.007), respectively. However, there was no significant difference in the mean SD LT and SD MT-LT between the two groups (p > 0.05). Conclusion . In addition to the advantage of reducing the cardiopulmonary radiation doses in left breast cancer, the DIBH technique could reduce the treatment delivery uncertainty compared to the FB method due to the significant reduction in the random inter-fraction dose variations.
- 30 June 2021
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 7 (4) , 045026
Quantifying inter- and intra-fraction variations of breast cancer radiotherapy with skin dose measurements
Aim . The aim of the current study was to compare between the deep inspiration breath-hold (DIBH) technique and free-breathing (FB) method in the treatment delivery uncertainty of breast cancer radiotherapy using skin dose measurements. Methods . In a prospective manner, eighty patients were randomly selected for skin dose measurements, and they were assigned to two groups. DIBH (40 patients) and FB (40 patients). The systematic inter-fraction dose variation was quantified using the mean percentage error (MPE) between the average measured total dose per session in three consecutive sessions and the corresponding calculated point dose from the treatment planning system. The random inter-fraction dose variation was quantified using the standard deviation (SD) of the dose delivered by the medial or lateral tangential fields, or the total session dose in the three sessions (SD MT , SD LT , or SD total , respectively). While the random intra-fraction dose variation was quantified using the SD of the dose difference between the medial and lateral tangential fields in three consecutive sessions (SD MT-LT ). Results . There was no statistically significant difference in MPE between the DIBH and FB groups (p = 0.583). Moreover, the mean SD total and SD MT of the DIBH group were significantly lower than that of the FB group (2.75 ± 2.33 cGy versus 4.45 cGy ± 4.33, p = 0.048) and (1.94 ± 1.63 cGy versus 3.76 ± 3.42 cGy, p = 0.007), respectively. However, there was no significant difference in the mean SD LT and SD MT-LT between the two groups (p > 0.05). Conclusion . In addition to the advantage of reducing the cardiopulmonary radiation doses in left breast cancer, the DIBH technique could reduce the treatment delivery uncertainty compared to the FB method due to the significant reduction in the random inter-fraction dose variations.
- 25 November 2020
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 7 (1) , 015004
The necessity of using deep inspiration breath-hold in the radiotherapy of left breast cancer patients who undergo the UK FAST trial
Aim : The purpose of the current study was to compare between deep inspiration breath-hold (DIBH) and free-breathing (FB) method in the setup reproducibility and to perform a dosimetric comparison between both methods in left-sided breast cancer patients who undergo the UK FAST trial. Materials and methods : The online matching correction data were retrospectively collected for 50 patients treated with the FAST trial. They were equally divided into DIBH and FB groups to compare between both methods in the setup reproducibility and create the appropriate planning target volume (PTV) margin. Ten patients out of the fifty were scanned in DIBH and FB to perform a dosimetric comparison with the strict acceptance criteria of the FAST trial. Results : All heart dosimetric parameters of the DIBH was significantly lower than that of FB (p < 0.001), and the lung V 30% of DIBH plans was significantly lower than FB plans (p = 0.03). There was no statistically significant difference between the two methods in the other organs at risk doses. To fulfill the heart and lung constraints in FB plans, the PTV V 90% was reduced by 3.4%, and three plans would not attain the PTV acceptance criteria. There was no significant difference between the systematic or random setup errors between both methods except the left-right random shift was significantly lower in DIBH cases (p = 0.004). The calculated PTV margins were (4 mm, 3 mm, and 4 mm) for DIBH group, and (5 mm, 6 mm, and 8 mm) for FB group in the anterior-posterior, superior-inferior, and left-right shifts, respectively. Conclusion : It is highly warranted to treat left-sided breast cancer patients with the DIBH technique when the UK FAST trial is employed for treatment.
- 25 November 2020
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 7 (1) , 015004
The necessity of using deep inspiration breath-hold in the radiotherapy of left breast cancer patients who undergo the UK FAST trial
Aim : The purpose of the current study was to compare between deep inspiration breath-hold (DIBH) and free-breathing (FB) method in the setup reproducibility and to perform a dosimetric comparison between both methods in left-sided breast cancer patients who undergo the UK FAST trial. Materials and methods : The online matching correction data were retrospectively collected for 50 patients treated with the FAST trial. They were equally divided into DIBH and FB groups to compare between both methods in the setup reproducibility and create the appropriate planning target volume (PTV) margin. Ten patients out of the fifty were scanned in DIBH and FB to perform a dosimetric comparison with the strict acceptance criteria of the FAST trial. Results : All heart dosimetric parameters of the DIBH was significantly lower than that of FB (p < 0.001), and the lung V 30% of DIBH plans was significantly lower than FB plans (p = 0.03). There was no statistically significant difference between the two methods in the other organs at risk doses. To fulfill the heart and lung constraints in FB plans, the PTV V 90% was reduced by 3.4%, and three plans would not attain the PTV acceptance criteria. There was no significant difference between the systematic or random setup errors between both methods except the left-right random shift was significantly lower in DIBH cases (p = 0.004). The calculated PTV margins were (4 mm, 3 mm, and 4 mm) for DIBH group, and (5 mm, 6 mm, and 8 mm) for FB group in the anterior-posterior, superior-inferior, and left-right shifts, respectively. Conclusion : It is highly warranted to treat left-sided breast cancer patients with the DIBH technique when the UK FAST trial is employed for treatment.